ArticleJournal of Korean medical science2010
Neurotoxic manifestations of an overdose intrathecal injection of gadopentetate dimeglumine.
Article in Journal of Korean medical science, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Trial
- Are gadolinium-based contrast media safe alternatives to iodinated contrast agents for the safe performance of spinal injection procedures?Interventional pain medicine · 2025Article
- Dopaminergic- and Serotonergic-Dependent Behaviors Are Altered by Lanthanide Series Metals inToxics · 2024Article
- The safety of magnetic resonance imaging contrast agents.Frontiers in toxicology · 2024Article
- Encephalopathy after unintentional intrathecal gadolinium: A letter to the editor.Interventional pain medicine · 2022Article
- Polyuria and polydipsia revealing a pituitary metastasis: Report of a rare case.Clinical case reports · 2022Article
- Does Impaired Glymphatic Drainage Cause Glymphedema? A Review Tailored to Neurocritical Care and Neurosurgery.Neurocritical care · 2021Review
- Unintentional direct intraventricular injection of gadolinium with fatal outcome: report of a case.Radiology case reports · 2021Article
- Gadolinium-based contrast agent-induced neurotoxicity: seeing is believing!BMJ case reports · 2021Article
- Off-label intrathecal use of gadobutrol: safety study and comparison of administration protocols.Neuroradiology · 2021Article
- Intrathecal use of gadobutrol for gadolinium-enhanced MR cisternography in the evaluation of patients with otorhinorrhea.Neuroradiology · 2020Article
- Neurotoxic manifestations of high-dose intrathecal gadolinium administration for CT myelogram.Radiology case reports · 2020Article
- Acute Encephalopathy and Cardiac Arrest Induced by Intrathecal Gadolinium Administration.Clinical neuroradiology · 2020Article
- A near-infrared probe for non-invasively monitoring cerebrospinal fluid flow byEJNMMI research · 2020Article
- Neurotoxicity from intrathecal gadolinium administration: Case presentation and brief review.Neurology. Clinical practice · 2020Article
- Intrathecal Use of Gadobutrol for Glymphatic MR Imaging: Prospective Safety Study of 100 Patients.AJNR. American journal of neuroradiology · 2019Observational
- Molecular Determinants of the Sensitivity to Gq/11-Phospholipase C-dependent Gating, Gd3+ Potentiation, and Ca2+ Permeability in the Transient Receptor Potential Canonical Type 5 (TRPC5) Channel.The Journal of biological chemistry · 2017Article
- MR myelography for identification of spinal CSF leak in spontaneous intracranial hypotension.AJNR. American journal of neuroradiology · 2014Article
- CSF otorhinorrhea in a child with inner ear dysplasia: diagnosis with T2-weighted and intrathecal contrast-enhanced MR cisternography.Japanese journal of radiology · 2014Article
- Intrathecal gadolinium-enhanced MR cisternography: a comprehensive review.AJNR. American journal of neuroradiology · 2013Review
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The intravenous administration of gadopentetate dimeglumine (GD) is relatively safe and rarely causes systemic toxicity in the course of routine imaging studies. However, the general safety of intrathecal GD has not been established. We report a very rare case of an overdose intrathecal GD injection presenting with neurotoxic manifestations, including a decreased level of consciousness, global aphasia, rigidity, and visual disturbance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.